531521 Stock Overview
Desh Rakshak Aushdhalaya Limited manufactures and sells ayurvedic and herbal products in India.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Desh Rakshak Aushdhalaya Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹7.29 |
| 52 Week High | ₹7.29 |
| 52 Week Low | ₹5.46 |
| Beta | -0.027 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | 78.24% |
| 5 Year Change | 78.24% |
| Change since IPO | -27.10% |
Recent News & Updates
Recent updates
Shareholder Returns
| 531521 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 0% | -1.4% | -1.6% |
| 1Y | n/a | 53.7% | 45.0% |
Return vs Industry: Insufficient data to determine how 531521 performed against the Indian Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how 531521 performed against the Indian Market.
Price Volatility
| 531521 volatility | |
|---|---|
| 531521 Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 531521 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 531521's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1901 | 24 | Tosh Jain | www.deshrakshak.in |
Desh Rakshak Aushdhalaya Limited manufactures and sells ayurvedic and herbal products in India. It manufactures and processes ayurvedic medicines, ayurvedic composite drug kits, dye kits, and CHW kits. The company also provides medicines in tablet, capsule, powder, syrup, and liquid forms.
Desh Rakshak Aushdhalaya Limited Fundamentals Summary
| 531521 fundamental statistics | |
|---|---|
| Market cap | ₹32.36m |
| Earnings (TTM) | ₹3.82m |
| Revenue (TTM) | ₹51.67m |
8.5x
P/E Ratio0.6x
P/S RatioIs 531521 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 531521 income statement (TTM) | |
|---|---|
| Revenue | ₹51.67m |
| Cost of Revenue | ₹18.06m |
| Gross Profit | ₹33.61m |
| Other Expenses | ₹29.79m |
| Earnings | ₹3.82m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.86 |
| Gross Margin | 65.04% |
| Net Profit Margin | 7.39% |
| Debt/Equity Ratio | 44.9% |
How did 531521 perform over the long term?
See historical performance and comparison